FRX do not have the ability to push the new drugs through the approval process at the FDA in a timely fashion. So, one has to be careful and should not be too optimistic about their approval of new drugs at the expected dates. Remember they are venturing into the new arena of innovative drugs from their traditional generic drugs business. So, there will be a long and painful learning process. Nobody knows their new management capabilities and their management culture.